Welcome to BioMarket Group!

    • The product Indian Biotechnology Market Outlook (2006) has been added to comparison list.

Indian Biotechnology Market Outlook (2006)

Additional Information

Published Date Feb 7, 2007
Special Offer No
Pages 90
PDF Fact Sheet View Fact Sheet for the report Indian Biotechnology Market Outlook (2006) in PDF format.
Published on Date No
Format No
Publisher RNCOS
Product Line No
Full Title No

Availability: In stock

Regular Price: $1,400.00

Special Price: $700.00

Quick Overview

The report "Indian Biotechnology Market Outlook (2006)" provides an updated and detailed overview of the Indian Biotechnology industry. It examines the emerging trends and provides exclusive forecasts and segment-wise snapshots of biotechnology industry in India. Report also highlights the information regarding Biotech parks in India and region-wise Biocluster.
Request free sample pages from Indian Biotechnology Market Outlook (2006)

The report "Indian Biotechnology Market Outlook (2006)" provides an updated and detailed overview of the Indian Biotechnology industry. It examines the emerging trends and provides exclusive forecasts and segment-wise snapshots of biotechnology industry in India. Report also highlights the information regarding Biotech parks in India and region-wise Biocluster.


Key Findings

- Growing at the rate of 28.09% from the year 2005, Indian Biotechnology industry is likely to touch the mark of US$ 5 Billion by the end of 2010.

- India will emerge as a key destination for clinical trials & stem cell research.

- Biotechnology will play an important role in Agriculture sector by developing large number of genetically modified crops.

- BioPharma industry, comprising of vaccines, therapeutics and other products, will emerge as major segment of Indian Biotech industry.

Key Issues and Facts Analyzed

The research report also addresses the issues and facts that are critical to your success:

- What are the market trends in the Indian Biotechnology industry?

- Where the market will be after 5 years?

- What opportunities exist in Indian Biotechnology industry?

- What are the driving factors for the Indian Biotechnology industry?

- What are the challenges faced by Biotechnology industry?

- Who are the main players in the Indian Biotechnology industry?

Key Players Analyzed

This section provides the overview and key financial information of prominent players in the Indian Biotechnology Industry, like Biocon, Serum Institute of India, Nicholas Piramal India Limited (NPIL), Wockhardt Limited, GlaxoSmithKline, Bharat Serums and Vaccines (BSV), Zydus Cadila, Indian Immunologicals Limited (IIL), Krebs Biochemical’s & Industries Limited (KBIL), Novo Nordisk, Mahyco Monsanto, Bharat Biotech, Abbott, Ranbaxy, Novozymes etc.


Research Methodology Used

Information Sources

Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods

The analysis methods includes the following: Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis using software tools, Judgmental Forecasting and Cause and Effect Analysis.

Request free sample pages from Indian Biotechnology Market Outlook (2006)

Other selected research from the 'Markets' category:


Insomnia Market Forecast
The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market... Learn More


Brazil Biofuel Market Outlook (2007-2010)
This report provides research and objective analysis of Brazilian biofuel industry. This report helps clients… Learn More

Other selected research from the 'India' category:


OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Datamonitor’s OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry... Learn More


The Top 10 CMOs in India: Market dynamics, competitive positioning and trends
India offers significant cost advantages over mature manufacturing hubs in Europe and North America. Both domestic pharmas and contract manufacturers (CMOs) are moving up the value chain into process development... Learn More